# Formulating Answerable Clinical Questions in Veterinary Medicine ## Key Takeaways - The PICO framework (Population, Intervention, Comparison, Outcome) is essential for formulating answerable clinical questions in veterinary medicine, ensuring clarity for systematic reviews and point-of-care decisions. - Precise specification of the Population is critical, encompassing species, breed, age, sex, reproductive status, disease stage, comorbidities, and production class to define external validity and avoid heterogeneous evidence. - The Intervention must be detailed, including dose, route, and duration for drugs, or technique and management for surgical procedures, to allow for replication and accurate comparison. - The Comparison component is vital for determining the effect measure; it should reflect the actual clinical decision, whether placebo, standard of care, or an alternative intervention. - Outcomes must be clinically meaningful, measurable, and pre-specified, ranging from patient-important endpoints like survival to surrogate markers or owner-reported measures, with adverse events also explicitly defined. - The PICOT extension adds Time (duration of follow-up) and Type of question (therapy, diagnosis, prognosis, harm, prevention), which dictates appropriate study designs and critical appraisal methods. --- Clinical questions that are poorly structured produce ambiguous searches, irreproducible evidence reviews, and conclusions that cannot be applied to the patient at hand. This article provides a framework for constructing answerable clinical questions in veterinary medicine, with emphasis on the PICO (Population, Intervention, Comparison, Outcome) structure and its extensions. It serves veterinary researchers designing systematic reviews, clinicians building search strategies for point-of-care decisions, and graduate students preparing research proposals. The content applies across species and clinical disciplines, from companion animal internal medicine to food animal production medicine. The central problem is that unstructured questions such as "does meloxicam work for dogs with osteoarthritis?" generate heterogeneous evidence that resists synthesis. A structured question forces explicit specification of the patient group, the intervention under study, the comparator, and the outcome of interest. This specification determines which studies are retrieved, how their quality is assessed, and whether their results can be pooled or compared. The same logic underpins the reporting standards that journals now expect from animal research, including the ARRIVE guidelines for transparent reporting of in vivo experiments and the EQUATOR Network's library of study-specific reporting checklists. ## At a Glance | Parameter | Specification | |---|---| | Core framework | PICO: Population, Intervention, Comparison, Outcome | | Primary extension | PICOT adds Time or Type of question | | Population | Species, breed, age, sex, reproductive status, disease stage, comorbidities, production class | | Intervention | Drug, dose, route, duration, surgical technique, diagnostic test, management protocol | | Comparison | Placebo, no treatment, standard of care, alternative intervention, different dose | | Outcome | Clinical endpoint, surrogate marker, adverse event, owner-reported measure, production parameter | | Question types | Therapy, diagnosis, prognosis, harm, prevention, cost-effectiveness | | Reporting standards | ARRIVE for animal research, EQUATOR library for human and animal study designs | ## The PICO Framework and Its Rationale PICO originated in evidence-based medicine as a mnemonic that forces the questioner to separate the components of a clinical query that determine study design and search strategy. Each component maps to a distinct element of the search filter and to specific inclusion criteria in a systematic review. The Population component defines the external validity boundary: results from a study of young laboratory Beagles may not transfer to geriatric Labrador Retrievers with comorbidities, and results from dairy cattle on pasture may not transfer to confined feedlot systems. The Intervention component must specify also the agent or procedure but also the dose, route, timing, and duration, because these parameters materially alter effect size and adverse event profiles. The Comparison component is frequently omitted in novice formulations, yet it determines the effect measure. A question that compares a new analgesic to placebo answers a different clinical question than one that compares it to the current standard of care. The Outcome component requires pre-specification of what will be measured, how it will be measured, and at what time point. Outcomes can be clinical (survival, remission), surrogate (biomarker concentration, imaging score), or owner-reported (quality of life, mobility scores). The choice of outcome determines whether the retrieved evidence can answer the question at all. ## Constructing the Population Component The Population must be specified with sufficient granularity to define a clinically meaningful group without being so narrow that no evidence exists. Species is the first delimiter, followed by breed where heritable or breed-predisposed conditions are involved. Age class matters for conditions with age-dependent pathophysiology, such as pediatric sepsis or degenerative joint disease in geriatric patients. Sex and reproductive status are relevant when hormonal status influences the disease or the intervention. Disease stage, severity, and duration of illness before intervention are critical modifiers of treatment response. Comorbidities and concurrent medications alter both efficacy and safety. Production class, housing system, and management practices are essential for food animals, where outcomes include growth, feed conversion, and carcass quality in addition to clinical endpoints. For example, a question about antimicrobial use in food animals requires specification of species, age class, production stage, and the disease condition being targeted. The World Health Organization guidelines on use of medically important antimicrobials in food-producing animals distinguish between growth promotion, disease prevention, and disease treatment, and the evidence base differs substantially across these indications. A PICO question that does not specify the indication will retrieve studies that cannot be compared. ## Defining Intervention and Comparison The Intervention component must be described at the level of detail that would allow replication. For a drug, this includes the active substance, formulation, dose, route, frequency, and duration. For a surgical procedure, it includes the technique, approach, and perioperative management. For a diagnostic test, it includes the test platform, sample type, and interpretation criteria. For a management protocol, it includes the specific components and their sequencing. The Comparison should be chosen to reflect the actual clinical decision being made. If the question is whether to use drug A or drug B, the comparison is head-to-head. If the question is whether to use drug A at all, the comparison is placebo or no treatment. If the question is whether a new diagnostic test adds value, the comparison is the existing standard test. The comparison determines the study designs that can answer the question. Head-to-head comparisons are best addressed by randomized trials, while questions about diagnostic accuracy require studies with blinded interpretation against a reference standard. ## Outcomes and the PICOT Extension Outcomes should be clinically meaningful, measurable, and specified in advance. A hierarchy exists from patient-important outcomes to surrogate endpoints. Survival, resolution of clinical signs, and quality of life sit at the top. Surrogate outcomes such as biomarker concentrations or imaging scores are easier to measure but may not correlate with clinical benefit. Adverse events are outcomes in their own right and must be specified as such, including the expected frequency and severity. The PICOT extension adds Time, which specifies the duration of follow-up or the time point at which the outcome is assessed. Time matters because some interventions show early benefit that dissipates, while others show delayed benefit. Time also determines the feasibility of the study design and the risk of attrition. The Type of question, sometimes added as a second T, classifies the question as therapy, diagnosis, prognosis, harm, or prevention, and this classification determines the preferred study design and the critical appraisal checklist. The Surviving Sepsis Campaign guidelines for children illustrate the application of PICO at scale. The guideline panel formulated each recommendation as a Population, Intervention, Control, and Outcomes question, conducted systematic reviews for each, and assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. This structured process allowed the panel to make recommendations across six domains, including recognition and management of infection, hemodynamics and resuscitation, and ventilation, while explicitly identifying areas where evidence was insufficient. The same discipline applies to a single clinical question posed by an individual practitioner. ## Common Formulation Errors and Their Consequences The most frequent error is an underspecified Population that conflates different disease stages or severity groups. A question about sepsis treatment that does not distinguish between septic shock and sepsis without shock will retrieve trials with different inclusion criteria and different baseline mortality risks, making the pooled effect estimate uninterpretable. A second error is an intervention description that omits dose or duration, which prevents the searcher from distinguishing studies of therapeutic dosing from studies of prophylactic dosing. A third error is an outcome that is measured differently across studies, such as combining owner-reported mobility scores with force plate gait analysis in a single synthesis. A fourth error is the failure to specify the comparison, which leads to retrieval of studies with heterogeneous control groups. A fifth error is the absence of a time frame, which makes it impossible to distinguish short-term from long-term effects. These errors compound when the question is used to build a search strategy, because each missing component broadens the search and reduces precision, or narrows it in ways that exclude relevant studies. The remedy is to write the question in full PICO format before beginning the search, then to test the question against a sample of known relevant studies to confirm that the formulation would retrieve them. ## Worked Examples Across Veterinary Contexts The value of a structured question becomes apparent when it is applied to real clinical scenarios. The following examples illustrate how the same clinical uncertainty can be translated into a searchable, answerable question across different species and practice settings. ### Example 1: Sepsis Resuscitation in Neonatal Foals A clinician managing a septic foal with refractory hypotension must decide between vasopressor strategies. The unstructured question, "What should I use for blood pressure support?" is too broad to generate useful evidence. A structured alternative: - **Population:** Neonatal foals (less than 7 days old) with septic shock and hypotension unresponsive to fluid resuscitation - **Intervention:** Norepinephrine continuous infusion - **Comparison:** Vasopressin continuous infusion - **Outcome:** Time to mean arterial pressure target, survival to discharge, incidence of arrhythmia The resulting question: "In neonatal foals with fluid-refractory septic shock, does norepinephrine compared with vasopressin achieve target mean arterial pressure faster and improve survival to discharge?" This structure mirrors the approach taken in the [Surviving Sepsis Campaign international guidelines for children](https://pubmed.ncbi.nlm.nih.gov/32030529/), which used explicit Population, Intervention, Control, and Outcomes questions for each recommendation. The pediatric guideline panel found that framing hemodynamic support questions in this format allowed systematic comparison of vasoactive agents across heterogeneous studies. Veterinary clinicians can adopt the same discipline even where the equine evidence base is thinner. ### Example 2: Antimicrobial Stewardship in Feedlot Cattle A production animal veterinarian advising a feedlot operation must evaluate whether metaphylactic antimicrobial use at arrival reduces subsequent morbidity. The question must specify the production system and the comparator clearly: - **Population:** High-risk beef calves (auction-sourced, commingled, unvaccinated) on arrival at a feedlot - **Intervention:** Metaphylactic administration of a medically important antimicrobial - **Comparison:** No metaphylaxis, with individual treatment on clinical diagnosis - **Outcome:** Morbidity rate, mortality rate, average daily gain, antimicrobial resistance prevalence in fecal isolates The structured question reads: "In high-risk auction-sourced beef calves at feedlot arrival, does metaphylactic use of a medically important antimicrobial compared with no metaphylaxis reduce morbidity and mortality without increasing antimicrobial resistance prevalence?" This formulation forces explicit consideration of the comparison group. The [WHO guidelines on use of medically important antimicrobials in food-producing animals](https://pubmed.ncbi.nlm.nih.gov/29375825/) recommend restricting use of these agents for disease prevention in healthy animals, and the guideline development group explicitly weighed evidence on growth promotion and prevention against resistance selection. A veterinary researcher evaluating metaphylaxis must therefore specify whether the comparator reflects current best practice or a hypothetical no-treatment baseline, because this choice changes the clinical and ethical interpretation of the results. ### Example 3: Diagnostic Accuracy in Canine Lymphoma Diagnostic questions require a modified structure. The standard PICO format assumes an intervention, but diagnostic accuracy studies compare a test against a reference standard: - **Population:** Dogs with peripheral lymphadenopathy suspected of lymphoma - **Index test:** Flow cytometric immunophenotyping of fine-needle aspirates - **Reference standard:** Histopathology of excisional lymph node biopsy - **Outcome:** Sensitivity, specificity, positive and negative likelihood ratios The question becomes: "In dogs with peripheral lymphadenopathy, does flow cytometric immunophenotyping compared with histopathology accurately distinguish lymphoma from reactive hyperplasia?" Diagnostic PICO questions should specify the disease spectrum in the population. A test that performs well in dogs with advanced, high-grade lymphoma may perform poorly in early disease or in indolent forms. The population component must therefore state the clinical presentation, also the target disease. ## Species, Production System, and Setting Considerations The correct formulation of each PICO component depends on context that the question must make explicit. **Species and breed:** Drug metabolism, disease pathogenesis, and reference intervals differ between species. A question about postoperative analgesia in dogs cannot be extrapolated to rabbits without specifying the species in the population component. Breed predispositions matter for genetic diseases and for conditions with breed-specific drug sensitivities. **Production system:** The same clinical problem in dairy cattle, beef cattle, and feedlot calves generates different questions because the outcomes of interest differ. A dairy question might prioritize milk production and somatic cell count, while a beef question prioritizes average daily gain and carcass quality. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) also introduce trade and surveillance considerations that may not apply in companion animal practice. **Patient status:** Emergency, critical care, and elective settings change the feasibility of interventions and the acceptable risk profile. A question about fluid resuscitation in septic shock differs from one about maintenance fluid therapy in an elective surgical patient, even when the species and intervention are identical. **Available equipment:** A question about point-of-care ultrasound for pericardial effusion diagnosis presumes the equipment is available. Where resource constraints exist, the question should specify the diagnostic modality actually accessible, or the results will not translate into practice change. ## A Checklist for Evaluating Question Structure Before committing to a literature search or study design, evaluate the question against the following criteria. Each item addresses a named failure mode. | Criterion | Question to ask | Common failure mode addressed | |---|---|---| | Population specificity | Does the population state species, age or life stage, and clinical status? | Overbroad populations that mix species or disease severities | | Intervention clarity | Is the intervention described with enough detail to replicate or compare? | Vague terms such as "supportive care" or "standard therapy" | | Comparison relevance | Does the comparison reflect the actual clinical alternative? | Comparing against placebo when the real choice is between two active treatments | | Outcome prioritization | Are outcomes ranked by clinical importance, not convenience? | Surrogate outcomes that do not correlate with patient-relevant endpoints | | Timeframe specification | Is the observation period stated where it affects interpretation? | Outcomes measured at incompatible time points across studies | | Setting declaration | Does the question state the practice or production context? | Results from one setting applied to another without justification | The [ARRIVE guidelines for reporting animal research](https://arriveguidelines.org/) emphasize that the methods section of a study must permit replication. The same logic applies to the clinical question: if a colleague cannot determine what population, intervention, and outcomes were intended, the question cannot be answered systematically. The [EQUATOR Network reporting guidelines library](https://www.equator-network.org/) provides reporting standards for the study designs that will ultimately answer these questions, and consulting the relevant standard at the question formulation stage improves the alignment between question and design. ## Documenting the Question for Research Protocols When the structured question will drive a research study instead of a literature search, documentation requirements increase. The question should appear in the protocol with each component explicitly labelled. The search strategy, inclusion criteria, and data extraction forms should all trace back to the PICO components. If the question changes during the study, the protocol must document the change and its rationale. For systematic reviews, the question determines the search string, the screening criteria, and the risk of bias assessment. A question with an underspecified population will generate a search that either misses relevant studies or retrieves an unmanageable volume of irrelevant records. The [WHO guideline development process](https://pubmed.ncbi.nlm.nih.gov/29375825/) illustrates this principle: each recommendation was built on a systematic review conducted for a specific Population, Intervention, Control, and Outcomes question, and the evidence assessment used the Grading of Recommendations Assessment, Development and Evaluation approach to link question structure to evidence quality. For primary research, the question determines the study design. A question about intervention efficacy points toward a randomised controlled trial or a prospective cohort study. A diagnostic accuracy question points toward a cross-sectional study with blinding between index test and reference standard. A prognostic question points toward a longitudinal cohort with explicit inclusion criteria and follow-up protocols. The question should be fixed before the design is selected, not adjusted afterward to fit the design. ## Recognized Complications and Early Detection Structured clinical questions fail in predictable ways, and most failures are detectable before the search begins. The first complication is population drift, where the question specifies a population that cannot be identified from the records or cases available. A question asking about "geriatric cats with chronic kidney disease" becomes unanswerable if the practice records do not consistently record International Renal Interest Society stage. Detect this early by auditing the data source against each population descriptor before committing to the question. The second complication is outcome substitution. Investigators often replace a clinically meaningful outcome with a measurable surrogate because the true outcome is expensive or slow to capture. This substitution is legitimate only when the surrogate has a validated relationship to the clinical endpoint. When that relationship is absent, the question answers itself but not the clinical problem. Detect this by asking whether the outcome would change management if it moved in the predicted direction. The third complication is comparison ambiguity. Questions that omit an explicit comparator, or that use "usual care" without defining what usual care contains, produce searches that cannot distinguish the effect of the intervention from the effect of concurrent treatment changes. This is particularly problematic in production animal medicine, where management changes often coincide with treatment protocols. Early detection requires writing the comparator as a concrete protocol, not a label. The fourth complication is scope creep, where the question expands during the search process to include adjacent populations or interventions. This usually reflects an unclear decision threshold in the original question. Detect it by re-reading the question after the first ten abstracts and asking whether each included study would have been anticipated. ## Common Errors and Corrective Action Less experienced question formulators consistently make several identifiable errors. The first is writing the population as a presenting complaint instead of a defined case. "Dogs with diarrhea" is not a population, "dogs with acute hemorrhagic diarrhea syndrome confirmed by canine parvovirus antigen testing" is. The corrective action is to specify the diagnostic criteria that define the case, drawing on standard references where available, such as the [MSD Veterinary Manual](https://www.msdvetmanual.com/) for species-specific case definitions. The second error is conflating the intervention with the diagnostic pathway. Students frequently write questions such as "In dogs with suspected lymphoma, does flow cytometry improve outcomes?" when the actual question concerns diagnostic accuracy. The corrective action is to recognize that diagnostic questions require a different outcome structure, one that reports sensitivity, specificity, and likelihood ratios instead of survival or remission. The third error is outcome stacking, where the formulator lists every conceivable outcome without prioritizing. This produces searches that return heterogeneous studies and forces post hoc selection. The corrective action is to designate one primary outcome and limit secondary outcomes to two or three that inform the same decision. The Surviving Sepsis Campaign pediatric guidelines illustrate this discipline, structuring each Population, Intervention, Control, and Outcomes question around a defined primary outcome before systematic review begins ([Surviving Sepsis Campaign international guidelines for children](https://pubmed.ncbi.nlm.nih.gov/32030529/)). The fourth error is temporal confusion in the PICOT extension. Formulators specify a time point that does not match the biology of the condition, such as measuring a response at 24 hours for a disease with a chronic course. The corrective action is to anchor the time point to the decision point, not to convention. ## Limitations of the Evidence Base The veterinary evidence base constrains what structured questions can answer. Many clinical questions in companion animal medicine have no directly applicable randomised trials, and the available evidence often comes from small single-center studies with heterogeneous outcome definitions. This limits the confidence with which any structured question can be answered, regardless of how well it is formulated. Expert opinion still differs on several substantive points. The role of antimicrobials for disease prevention in food-producing animals remains contested, with international guidance recommending restriction while acknowledging that the evidence base for alternatives is incomplete. The World Health Organization guidelines on medically important antimicrobials in food-producing animals explicitly recommend reductions in use for growth promotion and disease prevention, but the guidelines also note the need to assess feasibility and impact on equity across production systems ([WHO guidelines on antimicrobial use in food-producing animals](https://pubmed.ncbi.nlm.nih.gov/29375825/)). This means a structured question about metaphylaxis in feedlot cattle will encounter evidence that is shaped by policy position as much as by trial data. Diagnostic accuracy research in veterinary medicine faces similar constraints. Studies frequently use reference standards that are themselves imperfect, and the reporting quality varies. Reporting standards such as the ARRIVE guidelines and the EQUATOR Network resources exist to improve transparency, but their adoption in veterinary journals remains uneven ([ARRIVE guidelines for animal research reporting](https://arriveguidelines.org/), [EQUATOR Network reporting guidelines](https://www.equator-network.org/)). When constructing a diagnostic question, the formulator should check whether the planned outcome can be measured against a reference standard that the field accepts. ## Escalation and Referral Some questions cannot be answered from the available literature and require escalation. Referral to a specialist or diagnostic laboratory is warranted when the question depends on diagnostic techniques that the practice cannot perform, such as mass spectrometry-based metabolomics, where sample collection, preparation, and data interpretation require specialised infrastructure and expertise ([mass-spectrometry-based metabolomics limitations and recommendations](https://pubmed.ncbi.nlm.nih.gov/20046865/)). Similarly, questions about international animal health standards, such as trade-related disease control, should be checked against the World Organization for Animal Health terrestrial code instead of inferred from local practice ([WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/)). Regulatory reporting is required when the question touches on notifiable disease, antimicrobial resistance surveillance, or adverse event monitoring. The threshold for reporting varies by jurisdiction and species, and the formulator should consult the relevant national authority before proceeding. Professional practice resources from bodies such as the American Veterinary Medical Association can clarify the obligations that apply in a given setting ([AVMA practice resources](https://www.avma.org/resources-tools)). ## Troubleshooting Table | Observation | Likely Cause | Discriminating Check | |---|---|---| | Search returns no relevant studies | Population or intervention defined too narrowly | Broaden the population descriptor and re-run the search | | Search returns thousands of irrelevant studies | Outcome or comparator too generic | Rewrite the outcome with a measurable threshold | | Two reviewers disagree on study inclusion | Population criteria are ambiguous | Test the criteria against five known cases | | Results cannot be applied to the clinic population | Setting or production system not specified | Add the production system and management context | | Evidence contradicts clinical experience | Outcome substitution without validation | Verify the surrogate outcome against the clinical endpoint | | Question changes during the search | Scope creep from unclear decision threshold | Restate the decision the question is meant to inform | ## Frequently Asked Questions ### How Do I Formulate a PICO Question When the Ideal Comparison Intervention Is Not Feasible in My Setting? When the preferred comparator is unavailable, select the closest feasible alternative and name the difference explicitly in the question. For example, if a placebo-controlled trial of a new analgesic cannot proceed for welfare reasons, compare the intervention against the current standard protocol and state that the comparison is active-controlled. Document the deviation in the research protocol and in any resulting manuscript. The [EQUATOR Network reporting guidelines](https://www.equator-network.org/) require transparent description of comparator choices so readers can judge applicability. If the alternative comparator changes the clinical inference, acknowledge this limitation when interpreting the evidence synthesis. ### How Should the Population Component Change When I Move a Question From One Species to Another? Species transfer requires re-specifying every PICO element, also the species name. Pathophysiology, drug metabolism, and outcome measures differ across species, and a question valid in dogs cannot be assumed valid in cats or horses. Rebuild the population with species-specific inclusion criteria, age ranges, and comorbid conditions. Re-examine the intervention for species-specific contraindications and the outcome for species-appropriate measurement tools. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific clinical context that can help identify where assumptions break down. When extrapolating from one species to another, state the source species and the target species explicitly in the question. ### What Do I Do When the Evidence Base Contains No Studies Matching My PICO Question? A well-formed PICO question with no matching evidence is still valuable because it defines a research gap. Before concluding the evidence is absent, broaden the search systematically by relaxing one component at a time, starting with the outcome, then the intervention, then the population. If no studies remain, the question becomes a candidate for primary research or for a scoping review. The [WHO guidelines on antimicrobial use in food-producing animals](https://pubmed.ncbi.nlm.nih.gov/29375825/) illustrate how structured questions were used to identify evidence gaps and commission new systematic reviews. Report the empty search result explicitly in the protocol so future reviewers do not repeat the work. ### How Do Cost and Resource Constraints Affect the Structure of a Clinical Question? Cost and resource constraints belong in the comparison and outcome components, not in the population. If an expensive intervention is compared with a cheaper standard, the question should specify whether the outcome of interest is clinical efficacy alone or cost-effectiveness. A question asking "In dairy cows with mastitis, does treatment A compared with treatment B reduce clinical cure time" answers a different question than one asking whether treatment A is worth its additional cost. When resources are limited, consider a feasibility outcome such as treatment adherence or time to administration. The [Surviving Sepsis Campaign guidelines for children](https://pubmed.ncbi.nlm.nih.gov/32030529/) explicitly considered resource implications when formulating recommendations, demonstrating that resource awareness can be built into the question structure itself. ### What Level of Detail Should I Record When Documenting the PICO Question in Clinical Records or Research Files? Record the exact wording of the question, the date it was formulated, the clinical context that prompted it, and the person who formulated it. Include the search strategy used to locate evidence and the databases searched. Note any modifications made to the question during the search process and the reason for each change. This documentation supports reproducibility and allows the question to be revisited when new evidence emerges. The [ARRIVE guidelines for reporting animal research](https://arriveguidelines.org/) specify that the research question and objectives must be clearly stated in the methods, and the same discipline should apply to clinical records. A dated, versioned question also protects against retrospective rationalisation of an unsupported clinical decision. ### How Do I Explain a Structured Clinical Question to a Client or a Supervisor Who Is Unfamiliar With the PICO Format? Translate the structured question into plain clinical language without losing its precision. State the patient group, the intervention under consideration, the alternative, and the outcome that matters, in that order, using everyday terms. For a client, frame it as a decision: "We are comparing this treatment with the current standard to see which resolves the infection faster with fewer side effects." For a supervisor, present the same content but add the evidence context and the search plan. The [AVMA practice resources](https://www.avma.org/resources-tools) offer communication guidance that supports translating technical reasoning into accessible language. The goal is to preserve the logical structure while making the question intelligible to the decision-maker. ## Related Clinical & Scientific Guides * [Conducting Systematic Reviews of Veterinary Diagnostic Test Accuracy](/knowledge/veterinary-medicine/veterinary-research-methods/conducting-systematic-reviews-veterinary-diagnostic-test-accuracy) * [Bias in Veterinary Research: Types, Sources, and Mitigation](/knowledge/veterinary-medicine/veterinary-research-methods/bias-veterinary-research-types-sources-mitigation) * [Cluster Randomized Trials in Veterinary Research: Design and Analysis](/knowledge/veterinary-medicine/veterinary-research-methods/cluster-randomized-trials-veterinary-research-design-analysis) ## References and Further Reading - [Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.](https://pubmed.ncbi.nlm.nih.gov/32030529/). 2020. - [Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research.](https://pubmed.ncbi.nlm.nih.gov/20046865/). 2009. - [World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals.](https://pubmed.ncbi.nlm.nih.gov/29375825/). 2018. - [ARRIVE Guidelines 2.0 for Reporting Animal Research](https://arriveguidelines.org/). PLOS Biology, 2020. - [EQUATOR Network Reporting Guidelines](https://www.equator-network.org/). EQUATOR Network. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. - [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH. ## Related Articles - [Constructing Clinical Prediction Rules for Veterinary Medicine](/knowledge/veterinary-medicine/veterinary-research-methods/constructing-clinical-prediction-rules-veterinary-medicine) - [Designing Adaptive Clinical Trials for Veterinary Medicine](/knowledge/veterinary-medicine/veterinary-research-methods/designing-adaptive-clinical-trials-veterinary-medicine) - [Conducting Pharmacovigilance Studies in Veterinary Medicine](/knowledge/veterinary-medicine/veterinary-research-methods/conducting-pharmacovigilance-studies-veterinary-medicine) - [Blinding in Veterinary Clinical Research: Methods and Challenges](/knowledge/veterinary-medicine/veterinary-research-methods/blinding-veterinary-clinical-research-methods-challenges) - [Handling Missing Data in Veterinary Clinical Research](/knowledge/veterinary-medicine/veterinary-research-methods/handling-missing-data-veterinary-clinical-research) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.